Thus, limitations in curative and, especially, palliative treatment options of PDACs demonstrate a need for new and gemcitabine-independent strategies. 10, 11 Over the last couple of years, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback